Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10036000HBVENSG00000185010.15protein_codingF8NoNo2157P00451
TVIS10031972HBVENSG00000185010.15protein_codingF8NoNo2157P00451
TVIS30010023HIVENSG00000185010.15protein_codingF8NoNo2157P00451
TVIS30000259HIVENSG00000185010.15protein_codingF8NoNo2157P00451
TVIS30073897HIVENSG00000185010.15protein_codingF8NoNo2157P00451
TVIS30073898HIVENSG00000185010.15protein_codingF8NoNo2157P00451
TVIS30073899HIVENSG00000185010.15protein_codingF8NoNo2157P00451
TVIS30073900HIVENSG00000185010.15protein_codingF8NoNo2157P00451
TVIS30073901HIVENSG00000185010.15protein_codingF8NoNo2157P00451
TVIS30073902HIVENSG00000185010.15protein_codingF8NoNo2157P00451
TCGA Plot Options
Drug Information
GeneF8
DrugBank IDDB16007
Drug NameRurioctocog alfa pegol
Target IDBE0000016
UniProt IDP00451
Regulation Typeregulator
PubMed IDs33150384
CitationsKlamroth R, Windyga J, Radulescu V, Collins PW, Stasyshyn O, Ibrahim HM, Engl W, Tangada SD, Savage W, Ewenstein B: Rurioctocog alfa pegol PK-guided prophylaxis in hemophilia A: results from the phase 3 PROPEL study. Blood. 2021 Apr 1;137(13):1818-1827. doi: 10.1182/blood.2020005673.
GroupsApproved; Experimental
Direct ClassificationPeptides
SMILES
Pathways
PharmGKB
ChEMBL